-
Reply to Hatice Bolek's Letter to the Editor re: Hilin Yildirim, Katja K.H. Aben, Maarten J. Bijlsma, et al. A Nationwide Real-world Evaluation of Upfront Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma in the Immunotherapy Era. Eur Urol Oncol 2025;8:623-31
Yildirim, H., Bins, A. D., Bex, A. & Zondervan, P. J., 1 Oct 2025, In: European urology oncology. 8, 5, p. 1438-1439Research output: Contribution to journal › Article › Academic › peer-review
-
Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort
Yildirim, H., Richters, A., Bins, A. D., Postema, A. W., Aarts, M. J. B., van Oijen, M. G. H., Zondervan, P. J. & Aben, K. K. H., 1 Feb 2025, In: European urology open science. 72, p. 42-45 4 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
PrimerX: A Bayesian Multistage Cohort Embedded Randomised Trial to Evaluate the Role of Deferred Local Therapy of the Primary Tumour in Combination with Immune Checkpoint Inhibitor–based First-line Therapy in Metastatic Renal Cell Carcinoma Patients
Figaroa, O., Zondervan, P., Kessels, R., Berkhof, J., Aarts, M., Hamberg, P., Los, M., Piersma, D., Rikhof, B., Suelmann, B., Tascilar, M., van der Veldt, A., Verhagen, P., Westgeest, H., Yildirim, H., Bex, A. & Bins, A., 1 Dec 2024, In: European urology open science. 70, p. 28-35 8 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
